Trials / Completed
CompletedNCT02456961
Standard Corneal Collagen Crosslinking Versus Transepithelial Corneal Crosslinking by Iontophoresis of Riboflavin
Comparative Study of Results of Standard Corneal Collagen Crosslinking Versus Transepithelial Corneal Crosslinking by Iontophoresis of Riboflavin: a Randomized Control Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 126 (actual)
- Sponsor
- Ufa Eye Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The standard CXL technique involves removal of the epithelium to enable riboflavin to penetrate into stromal tissue, to avoid epithelial debridement and increasing the patient's comfort and safety transepithelial corneal crosslinking (CXL) was suggested. Iontophoresis of riboflavin is one of approach for riboflavin impregnation. In this study, the investigators compared the results of standard corneal crosslinking (CXL) and transepithelial CXL via iontophoresis of riboflavin after 24 months follow up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | iontophoresis of riboflavin | |
| PROCEDURE | epithelium-off | |
| PROCEDURE | Corneal collagen crosslinking | Standard surface UVA irradiation (370 nm, 3 mW/cm2; UFalink, Russian Federation) was then applied at a 5-cm distance for 30 minutes. During UVA exposure, hypotonic riboflavin drops were continued every 2 minutes. |
| DEVICE | galvanizator, Potok-1 | Device for providing iontophoresis procedure |
| DRUG | Dextralink | Riboflavin 0,1% + Dextran T-500 |
| DRUG | Riboflavin 0,1% | |
| DEVICE | UFalink | device for UVA irradiation - providing UVA light - 370 nm, 3 mW/cm2 |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2015-05-29
- Last updated
- 2015-05-29
Source: ClinicalTrials.gov record NCT02456961. Inclusion in this directory is not an endorsement.